| 000 | 01061 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514052752.0 | ||
| 264 | 0 | _c20021224 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a1568-0053 | ||
| 024 | 7 |
_a10.2174/1568005024605855 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHancock, R E W | |
| 245 | 0 | 0 |
_aClinical development of cationic antimicrobial peptides: from natural to novel antibiotics. _h[electronic resource] |
| 260 |
_bCurrent drug targets. Infectious disorders _cMar 2002 |
||
| 300 |
_a79-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aBacteria _xdrug effects |
| 650 | 0 | 4 | _aCations |
| 650 | 0 | 4 | _aCombinatorial Chemistry Techniques |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aPeptides |
| 700 | 1 | _aPatrzykat, A | |
| 773 | 0 |
_tCurrent drug targets. Infectious disorders _gvol. 2 _gno. 1 _gp. 79-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568005024605855 _zAvailable from publisher's website |
| 999 |
_c12267564 _d12267564 |
||